Anlotinib may enhance the efficacy of anti-PD1 therapy by inhibiting the AKT pathway and promoting the apoptosis of CAFs in lung adenocarcinoma

作者：Hui Tang, Tingting You, Hui Ge, Jingxi Gao, Yingyi Wang, Chunmei Bai, Zhao Sun, Qin Han, Robert Chunhua Zhao · 发表于：International Immunopharmacology · 年份：2024 · DOI：10.1016/j.intimp.2024.112053 · 被引用次数：24 · 研究领域：Immune cells in cancer、Lung Cancer Research Studies、Cancer Immunotherapy and Biomarkers